APX.AX stock A$1.08 pre-market 22 Jan 2026: earnings and AI demand to watch
APX.AX stock trades at A$1.08 in pre-market on 22 Jan 2026, down 3.57% on the session. Appen Limited (APX.AX) on the ASX shows heavy interest with 4,665,210.00 shares changing hands versus an average of 2,955,443.00. The move comes as investors weigh a negative EPS of A$-0.12 and AI data demand that can swing revenue. We use Meyka AI’s models and sector context to outline why earnings and AI contract wins matter for short-term price action and medium-term value.
APX.AX stock: current price and trading snapshot
Appen Limited (APX.AX) is quoted on the ASX at A$1.08 with a day low of A$1.00 and day high of A$1.09. Volume is 4,665,210.00, above the 50-day average of 2,955,443.00, giving a relative volume of 1.89. Market capitalisation stands at A$278,891,171.00 and shares outstanding are 265,610,639.00. The stock opened at A$1.02 and closed previously at A$1.12, signaling intraday pressure into the pre-market session.
APX.AX stock: earnings, financials and valuation
Appen reports EPS of A$-0.12 and a trailing PE of -8.75, reflecting recent losses. Revenue per share is A$1.34 and price to sales sits at 0.79, while price to book is 1.88. Recent growth shows revenue decline of 43.04% year-over-year to the last fiscal year and gross profit contraction of 73.07%. Appen’s next earnings announcement is scheduled for 02 Mar 2026, a key catalyst for the price given margins and cash flow volatility.
APX.AX stock: Meyka AI rates and forecast
Meyka AI rates APX.AX with a score out of 100. Meyka AI rates APX.AX with a score of 62.12 out of 100 — Grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a monthly price of A$1.36, implying an upside of 25.93% from the current A$1.08. The model also shows a conservative yearly projection of A$0.59, implying downside of 45.55%. Forecasts are model-based projections and not guarantees.
APX.AX stock: technicals and market signals
Momentum indicators show short-term strength and risk. RSI is 75.43 (overbought) and ADX 41.62 indicates a strong trend. The 50-day average is A$0.78 and the 200-day average is A$0.91, both below the current price, hinting at a recent recovery from the lows. On-chain volume and on-balance-volume suggest institutional interest but the Money Flow Index at 76.05 flags distribution. Traders should watch MACD histogram and volume spikes around earnings.
APX.AX stock: risks and AI market opportunity
Appen operates in AI data services, an attractive secular market as models demand labeled data. Risks include negative margins, net loss per share A$-0.12, and days sales outstanding of 74.86, which pressure working capital. The technology sector on the ASX trades at higher multiples, so valuation upside requires margin recovery and repeatable AI contracts. Positive catalysts include large enterprise deals and improved operating cash flow.
APX.AX stock: price targets and scenario analysis
No formal analyst price consensus is available, so we offer realistic targets tied to performance and sector recovery. Conservative target A$0.80 implies downside -25.93%. Base case A$1.40 implies upside 29.63%. Bull case A$2.20 implies upside 103.70%, tied to stronger AI contract wins and margin recovery. Use these targets as scenario markers, not guarantees.
Final Thoughts
APX.AX stock trades at A$1.08 pre-market on 22 Jan 2026, and the company sits at the intersection of AI demand and operational recovery. Key positives are a clear addressable market in AI data and a healthy current ratio of 2.77, which supports execution through cyclical revenue swings. Key negatives are a trailing EPS of A$-0.12, negative operating margins, and year-over-year revenue decline of 43.04%. Meyka AI’s model projects a monthly price of A$1.36, implying 25.93% upside, while a conservative yearly projection sits at A$0.59, implying -45.55% downside. Investors focused on AI stocks should watch the 02 Mar 2026 earnings release, contract announcements, and whether operating cash flow continues to improve. For ASX and AUD-based portfolios, APX.AX offers a high-volatility AI exposure with defined catalysts and measurable valuation pathways. See Appen investor filings and our Meyka AI page for ongoing updates.
FAQs
What is the current price and market data for APX.AX stock?
APX.AX stock is at A$1.08 pre-market on 22 Jan 2026. Volume is 4,665,210.00, market cap A$278,891,171.00, EPS A$-0.12, and PE -8.75. The next earnings date is 02 Mar 2026.
What does Meyka AI forecast for APX.AX stock?
Meyka AI’s forecast model projects a monthly price of A$1.36 for APX.AX stock, implying 25.93% upside from A$1.08. The yearly projection is A$0.59. Forecasts are model-based and not guarantees.
What are the main risks for APX.AX stock investors?
Key risks for APX.AX stock include ongoing negative profitability, revenue decline of 43.04%, high days sales outstanding 74.86, and concentration risk in large AI contracts. Operational cash flow and margin recovery are critical.
Which catalysts could move APX.AX stock?
Catalysts include the 02 Mar 2026 earnings report, new enterprise AI data contracts, improvements in operating cash flow, and sector re-rating in ASX technology names. Positive contract news could drive the price above the 50-day average.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
